Serum samples collected from feral swine (Sus scrofa) throughout Florida (USA) from 1980 to 1989 were tested for antibodies to pseudorabies virus (PRV) by the serum neutralization test, the latex agglutination test, or by the enzyme-linked immunosorbent assay. Seropositive swine were detected at 11 of 13 sites with a composite seroprevalence of 34.8% (579 of 1,662 samples; range = 5.9% to 58.2%) for sites with seropositive swine. Data on age and sex of the swine were available from three sites. Seroprevalence in males and females did not differ significantly (P = 0.62 for the combined data). Seroprevalence in adult (> or = 8 mo) and juvenile swine (< 8 mo) was significantly different at all sites (P < 0.05 for the combined data). From these data, PRV infections appear to occur widely in populations of Florida feral swine and may seriously undermine efforts to eradicate this virus from the domestic swine population of the USA.
Pigs were vaccinated by scarification or intramuscular injection with a swinepox virus-Aujeszky's disease (pseudorabies) recombinant (rSPV-AD) constructed by inserting the linked Aujeszky's disease virus genes coding for glycoproteins gp50 and gp63, attached to a vaccinia virus p7.5 promoter, into the thymidine kinase gene of swinepox virus. By 21 days after vaccination, 90 and 100 per cent of the animals vaccinated by scarification or intramuscular injection, respectively, had developed serum neutralising antibodies to Aujeszky's disease virus. Upon challenge with virulent virus, significantly fewer vaccinated pigs developed clinical Aujeszky's disease, nasal shedding of challenge virus was markedly reduced, and the vaccinated groups of pigs maintained or gained weight during the week after challenge whereas the unvaccinated control group lost weight. No transmission of rSPV-AD to in-contact controls was detected during the three weeks before challenge. In a second experiment, serum neutralising antibodies to Aujeszky's disease virus persisted for 150 days after the pigs were vaccinated with rSPV-AD by scarification or intramuscular injection and all the pigs showed an anamnestic response when they were revaccinated.
It remains a challenge for the role of the dairy veterinarian to move beyond that traditionally held. In larger herds with a high reproductive workload, we are at great risk of becoming specialist technicians. Instead we seek greater involvement, to deliver comprehensive services and to be recognised for them, personally and financially. Given the frequency of our visits, knowledge and analytical skills we are in a unique position to provide inputs that complement advice given by other consultants. Failure to do so has economic consequences for both veterinarian and dairyman. The opportunity for and value of inputs will differ for every client, and we need to remain cognizant of their motivation. This review article shares perspectives, opportunities and tools that might enable moving beyond the traditional role. It starts with a review of available research describing the dynamic between dairyman and veterinarian and how this might impact an animal health production management programme. A description of the experiences of others follows, interspersed by the personal experiences of the author, working with large total mixed ration-fed herds in the United States of America. The following attributes and roles can be associated with a significant economic impact: gatekeeper; conduit; executor; verifier; monitor; facilitator and mediator; trainer, motivator and coach; applied nutritionist; technologist; champion of animal welfare, food safety and judicious antibiotic use; and confidant. Each is elucidated and described in context, revealing a need for continuing education. The nature of the relationship between veterinarian and client will determine the opportunity for and value of each. The veterinarian is in a unique position to become an integral part of the management team and to be fairly compensated as such. The onus rests on the veterinarian to broaden his/her knowledge and skills and to demonstrate their value.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.